The use of the tyrosine kinase inhibitor Nilotinib in Spondyloarthritis: does targeting inflammatory pathways with a treatment lead to vascular toxicity?

類似資料

• A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis
  著者:: Paramarta, Jacqueline E., 等
  出版事項: (2016)
• Improvement of peripheral artery disease with Sildenafil and Bosentan combined therapy in a patient with limited cutaneous systemic sclerosis: A case report
  著者:: Omarjee, Loukman, 等
  出版事項: (2017)
• Performance of noninvasive laser Doppler flowmetry and laser speckle contrast imaging methods in diagnosis of Buerger disease: A case report
  著者:: Omarjee, Loukman, 等
  出版事項: (2018)
• Nilotinib: a Novel, Selective Tyrosine Kinase Inhibitor
  著者:: Blay, Jean-Yves, 等
  出版事項: (2011)
• Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia
  著者:: Pasvolsky, Oren, 等
  出版事項: (2015)